Search


 
Results 11 - 20 of about 32 for "FDA update".

March 23, 2018 | ACP Gastroenterology Monthly

... mothers with chronic HBV. FDA update. FDA sends warning to duodenoscope manufacturers. The manufacturers have not ...

December 22, 2017 | ACP Gastroenterology Monthly

... induced hepatotoxicity. FDA update. Biosimilar approved for certain cases of breast, metastatic stomach cancer. The drug ...

Drug for chronic idiopathic constipation approved | ACP ...

The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.

October 27, 2017 | ACP Gastroenterology Monthly

... eight years ago. FDA update. Warning issued on dosing of drug for primary biliary cholangitis. Clinicians should determine ...

March 24, 2017 | ACP Gastroenterology Monthly

... HIV co-infection. FDA update. IBS-D drug should not be prescribed to patients without gallbladders. The FDA suggests that ...

January 26, 2018 | ACP Gastroenterology Monthly

... FDA update. Proton-pump inhibitor recalled. One lot of pantoprazole sodium for injection (40 mg per vial) was recalled in December. ...

Duodenoscopes recalled | ACP Gastroenterology Monthly

The recall of ED-530XT duodenoscopes by Fujifilm includes replacement of the ED-530XT forceps elevator mechanism (including the O-ring seal), ...

New HCV drug combo approved | ACP Gastroenterology ...

The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.

Potency concerns lead to recall of anti-diarrhea drug | ACP ...

Recalled batches of diphenoxylate hydrochloride and atropine sulfate, an adjunctive therapy for the management of diarrhea, were distributed nationwide ...

Generic form of mesalamine approved | ACP ...

The drug is indicated to induce remission in adults with active, mild to moderate ulcerative colitis and to maintain remission of ulcerative colitis.

Result Page: < Previous  1 2 3 4  Next >